Jennifer R Grandis

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Radiation Therapy

Epidermal Growth Factor Receptor

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Rex H Lee, Ritu Roy, Hua Li, Aaron Hechmer, Tian Ran Zhu, Adila Izgutdina, Adam B Olshen, Daniel E Johnson, Jennifer R Grandis
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PloS one 18 (3) (2023)
Rex H Lee, Ritu Roy, Hua Li, Aaron Hechmer, Tian Ran Zhu, Adila Izgutdina, Adam B Olshen, Daniel E Johnson, Jennifer R Grandis
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PloS one 18 (3) (2023)
Rex H Lee, Daniel E Johnson, Jennifer R Grandis
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer. Cancer research 83 (19) (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rex H Lee, Ritu Roy, Hua Li, Aaron Hechmer, Tian Ran Zhu, Adila Izgutdina, Adam B Olshen, Daniel E Johnson, Jennifer R Grandis
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PloS one 18 (3) (2023)
Sankar Jagadeeshan, Manu Prasad, Mai Badarni, Talal Ben Lulu, Vijayasteltar Belsamma Liju, Sooraj Mathukkada, Claire J Saunders, Avital Beeri Shnerb, Jonathan Zorea, Ksenia M Yegodayev, Monica Wainer, Liza Vtorov, Irit Allon, Ofir Cohen, Gro Gausdal, Dinorah Friedmann-Morvinski, Sok Ching Cheong, Alan L Ho, Ari J Rosenberg, Linda Kessler, Francis Burrows, Dexin Kong, Jennifer R Grandis, Jorge Silvio Gutkind, Moshe Elkabets
Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer. Cancer research (2023)
Zoya Qureshy, Hua Li, Yan Zeng, Jose M Rivera, Ning Cheng, Christopher N Peterson, Grace E Kim, William R Ryan, Patrick K Ha, Julie E Bauman, Steven J Wang, Steven R Long, Daniel E Johnson, Jennifer R Grandis
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Jennifer R Grandis
Gender Equity in Science and Medicine: Breaking the Impasse. Cancer discovery 12 (5) (2022)
Neil E Bhola, Christian Njatcha, Lanlin Hu, Eliot D Lee, Jamie V Shiah, Mi-Ok Kim, Daniel E Johnson, Jennifer R Grandis
PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance. Head & neck 43 (11) (2021)
Danielle L Swaney, Dana J Ramms, Zhiyong Wang, Jisoo Park, Yusuke Goto, Margaret Soucheray, Neil Bhola, Kyumin Kim, Fan Zheng, Yan Zeng, Michael J McGregor, Kari A Herrington, Rachel A O'Keefe, Nan Jin, Nathan K VanLandingham, Helene Foussard, John Von Dollen, Mehdi Bouhaddou, David Jimenez-Morales, Kirsten Obernier, Jason F Kreisberg, Minkyu Kim, Daniel E Johnson, Natalia Jura, Jennifer R Grandis, Jorge Silvio Gutkind, Trey Ideker, Nevan J Krogan
A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. Science (New York, N.Y.) 374 (6563) (2021)
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, William E Gooding, Hua Li, Neil E Bhola, Tian Ran Zhu, Yan Zeng, Toni M Brand, Mi-Ok Kim, Richard C K Jordan, Scott VandenBerg, Victor Olivas, Trever G Bivona, Simion I Chiosea, Lin Wang, Gordon B Mills, Jonas T Johnson, Umamaheswar Duvvuri, Robert L Ferris, Patrick Ha, Daniel E Johnson, Jennifer R Grandis
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer. The Journal of experimental medicine 216 (2) (2019)
Chaoyang Sun, Yong Fang, Jun Yin, Jian Chen, Zhenlin Ju, Dong Zhang, Xiaohua Chen, Christopher P Vellano, Kang Jin Jeong, Patrick Kwok-Shing Ng, Agda Karina B Eterovic, Neil H Bhola, Yiling Lu, Shannon N Westin, Jennifer R Grandis, Shiaw-Yih Lin, Kenneth L Scott, Guang Peng, Joan Brugge, Gordon B Mills
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science translational medicine 9 (392) (2018)